Western Magnesium: Focused on Clean Production

Western Magnesium’s technology uses a continuous, silicothermic process to produce pure magnesium. Also, this method reduces labor and energy costs. T …

Western MAgnesium has no toxic by-products

Western Magnesium gears up to be the world's low cost producer of high quality magnesium.

Western Magnesium’s technology uses a continuous, silicothermic process to produce pure magnesium. Also, this method reduces labor and energy costs. This means that it generates no toxic by-products. This proprietary technology will set the standard for clean production.

To continue, this technology allows for the mass production of magnesium with few of the attendant environmental issues that hurt traditional production methods. Inasmuch, Western Magnesium’s technology wins on its merits by producing a high-quality, lower cost, greener product.

About Magnesium

Magnesium is one of the Earth’s most plentiful elements and in increasing demand by advanced manufacturers. However, supply is throttled due to a lack of research and development into faster, cleaner magnesium production technologies.

Moreover, magnesium metal has long been considered the coveted metal of industrial manufacturing. A third lighter than aluminum, 60% lighter than titanium and 75% lighter than steel.

All in all, magnesium’s strength and castability makes it an obvious replacement for any component that needs to be lighter and stronger to meet federally mandated efficiency standards.

For more information on Western Magnesium (WMG: TSX.V, OTCQB:MLYF) please fill out the form below.

You might also like

Ivan Bebek on Where the Biggest Mining Returns May Still Lie
Metals & Mining
March 4, 2026

Ivan Bebek on Where the Biggest Mining Returns May Still Lie

Veteran mining entrepreneur Ivan Bebek believes the current gold and silver cycle may only be getting started.

This is some text inside of a div block.
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Health & Wellness
March 3, 2026

Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine

Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.

This is some text inside of a div block.
BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs
ETFs
March 3, 2026

BMO ETFs Highlights Simplicity and Low Cost in Asset Allocation ETFs

In Canada, management fees for asset allocation ETFs can range from approximately 50 basis points down to 15 basis points.

This is some text inside of a div block.
Subscribe and receive the investor Info